Safety and long-term efficacy of cryoballoon ablation for atrial fibrillation in octogenarians: a multicenter experience

[1] Hindricks G(2021)2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J 42 373-498

[2] Potpara T(1987)The natural history of lone atrial fibrillation. A population-based study over three decades N Engl J Med. 317 669-674

[3] Dagres N(2006)Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence Circulation 114 119-125

[4] Kopecky SL(2011)Use of antiarrhythmic drugs in elderly patients: Use of antiarrhythmic drugs in elderly patients J Geriatr Cardiol 8 184-194

[5] Gersh BJ(2013)Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial J Am Coll Cardiol 61 1713-1723

[6] McGoon MD(2016)Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation N Engl J Med 374 2235-2245

[7] Miyasaka Y(2016)One-year follow-up after second-generation cryoballoon ablation for atrial fibrillation in a large cohort of patients: a single-centre experience Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol 18 987-993

[8] Barnes ME(2018)Pulmonary vein isolation cryoablation for patients with persistent and long-standing persistent atrial fibrillation: Clinical outcomes from the real-world multicenter observational project Heart Rhythm 15 363-368

[9] Gersh BJ(2016)One-year clinical outcome after pulmonary vein isolation in persistent atrial fibrillation using the second-generation 28 mm cryoballoon: a retrospective analysis EP Eur 18 201-205

[10] Hon-Chi L(2021)Cryoballoon ablation vs antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation EP Eur 23 1033-1041

[1] Hindricks G(2021)2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J 42 373-498

[2] Potpara T(1987)The natural history of lone atrial fibrillation. A population-based study over three decades N Engl J Med. 317 669-674

[3] Dagres N(2006)Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence Circulation 114 119-125

[4] Kopecky SL(2011)Use of antiarrhythmic drugs in elderly patients: Use of antiarrhythmic drugs in elderly patients J Geriatr Cardiol 8 184-194

[5] Gersh BJ(2013)Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the North American Arctic Front (STOP AF) pivotal trial J Am Coll Cardiol 61 1713-1723

[6] McGoon MD(2016)Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation N Engl J Med 374 2235-2245

[7] Miyasaka Y(2016)One-year follow-up after second-generation cryoballoon ablation for atrial fibrillation in a large cohort of patients: a single-centre experience Eur Eur Pacing Arrhythm Card Electrophysiol J Work Groups Card Pacing Arrhythm Card Cell Electrophysiol Eur Soc Cardiol 18 987-993

[8] Barnes ME(2018)Pulmonary vein isolation cryoablation for patients with persistent and long-standing persistent atrial fibrillation: Clinical outcomes from the real-world multicenter observational project Heart Rhythm 15 363-368

[9] Gersh BJ(2016)One-year clinical outcome after pulmonary vein isolation in persistent atrial fibrillation using the second-generation 28 mm cryoballoon: a retrospective analysis EP Eur 18 201-205

[10] Hon-Chi L(2021)Cryoballoon ablation vs antiarrhythmic drugs: first-line therapy for patients with paroxysmal atrial fibrillation EP Eur 23 1033-1041